INDUSTRY OVERVIEW
The Active Implantable Medical Devices is Growing at 20% and is expected to reach 18Billion by 2031. Below mentioned are some of the dynamics shaping the Active Implantable Medical Devices .Active Implantable Medical Devices Market Size in (USD Billion) CAGR Growth Rate 20%
| Study Period | 2019-2031 |
| Market Size (2023): | 7Billion |
| Market Size (2031): | 18Billion |
| CAGR (2023 - 2031): | 20% |
| Fastest Growing Region | Europe |
| Dominating Region | North America |
www.www.htfmarketinsights.com
An active implantable medical device is a device, which is hereby intended to be either wholly or partially put into the human body surgically or medically or through the process of a medical procedure into a natural opening and that it should remain inside the body even after the procedure. It is a medical device that is intended to be wholly or partially introduced into the human body for diagnostic or therapeutic purposes and is intended to remain in place. These benefit remarkably from the increasing spread of several chronic diseases such as cardiovascular and neurological diseases. The constant product launches and the simplified approval process also support the growth of this market considerably.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- The Increasing Number Of Patients With Cardiovascular Diseases And Neurological Disorders
- Growth In Aging Population
- Demand For Implantable Cardioverter Defibrillators
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- Regulation
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Minimally Invasive
- Personalization
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Healthcare Reforms For Infrastructural Development
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Pacemakers
- Defibrillators
- Cochlear Implants
- Neurostimulators
Active Implantable Medical Devices Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Healthcare
- Hospitals
- Neurosurgery
- Cardiology
- Biotech
Active Implantable Medical Devices Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Europe is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Europe
Dominating Region
North America
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Medtronic (Ireland)
- Abbott Laboratories (United States)
- Boston Scientific Corporation (United States)
- BIOTRONIK (Germany)
- LivaNova PLC (United Kingdom)
- Cochlear Limited (Australia)
- MED-EL (Austria)
- Sonova (Switzerland)
- Demant (Denmark)
Active Implantable Medical Devices Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2023 |
|
Based Year Market Size (2023) |
7Billion |
|
Historical Period |
2019 to 2023 |
|
CAGR (2023 to 2031) |
20% |
|
Forecast Period |
2023 to 2031 |
|
Forecasted Period Market Size (2031) |
18Billion |
|
Scope of the Report |
Segmentation by Type
Segmentation by Application
|
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Medtronic (Ireland), Abbott Laboratories (United States), Boston Scientific Corporation (United States), BIOTRONIK (Germany), LivaNova PLC (United Kingdom), Cochlear Limited (Australia), MED-EL (Austria), Sonova (Switzerland), Demant (Denmark) |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Active Implantable Medical Devices - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Active Implantable Medical Devices Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Active Implantable Medical Devices Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Active Implantable Medical Devices Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 The Increasing Number of Patients with Cardiovascular Diseases and Neurological Disorders
- 3.1.2 Growth in Aging Population
- 3.1.3 Demand For Implantable Cardioverter Defibrillators
-
3.2 Available Opportunities
- 3.2.1 Healthcare Reforms for Infrastructural Development
- 3.2.2 Technological Advancements in Developing Novel Active Implantable
-
3.3 Influencing Trends
- 3.3.1 Minimally Invasive
- 3.3.2 Personalization
- 3.3.3 Biocompatibility
-
3.4 Challenges
- 3.4.1 Regulation
- 3.4.2 Sourcing
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Active Implantable Medical Devices Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Active Implantable Medical Devices Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Active Implantable Medical Devices : Competition Benchmarking & Performance Evaluation
- 5.1 Global Active Implantable Medical Devices Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Active Implantable Medical Devices Revenue 2023
- 5.3 Global Active Implantable Medical Devices Sales Volume by Manufacturers (2023)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 5C’s Analysis
- 5.6 Ansoff Matrix
Chapter 6: Global Active Implantable Medical Devices Market: Company Profiles
- 6.1 Medtronic (Ireland)
- 6.1.1 Medtronic (Ireland) Company Overview
- 6.1.2 Medtronic (Ireland) Product/Service Portfolio & Specifications
- 6.1.3 Medtronic (Ireland) Key Financial Metrics
- 6.1.4 Medtronic (Ireland) SWOT Analysis
- 6.1.5 Medtronic (Ireland) Development Activities
- 6.2 Abbott Laboratories (United States)
- 6.3 Boston Scientific Corporation (United States)
- 6.4 BIOTRONIK (Germany)
- 6.5 LivaNova PLC (United Kingdom)
- 6.6 Cochlear Limited (Australia)
- 6.7 MED-EL (Austria)
- 6.8 Sonova (Switzerland)
- 6.9 Demant (Denmark)
- 6.10 Nurotron Biotechnology (United States)
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Active Implantable Medical Devices by Type & Application (2019-2031)
-
7.1 Global Active Implantable Medical Devices Market Revenue Analysis (USD Million) by Type (2019-2023)
- 7.1.1 Pacemakers
- 7.1.2 Defibrillators
- 7.1.3 Cochlear Implants
- 7.1.4 Neurostimulators
- 7.1.5 Drug Pumps
-
7.2 Global Active Implantable Medical Devices Market Revenue Analysis (USD Million) by Application (2019-2023)
- 7.2.1 Healthcare
- 7.2.2 Hospitals
- 7.2.3 Neurosurgery
- 7.2.4 Cardiology
- 7.2.5 Biotech
- 7.3 Global Active Implantable Medical Devices Market Revenue Analysis (USD Million) by Type (2023-2031)
- 7.4 Global Active Implantable Medical Devices Market Revenue Analysis (USD Million) by Application (2023-2031)
Chapter 8 : North America Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 8.1 North America Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 8.2.1 Pacemakers
- 8.2.2 Defibrillators
- 8.2.3 Cochlear Implants
- 8.2.4 Neurostimulators
- 8.2.5 Drug Pumps
-
8.3 North America Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 8.3.1 Healthcare
- 8.3.2 Hospitals
- 8.3.3 Neurosurgery
- 8.3.4 Cardiology
- 8.3.5 Biotech
- 8.4 North America Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 8.5 North America Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 8.6 North America Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 9.1 LATAM Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 9.2.1 Pacemakers
- 9.2.2 Defibrillators
- 9.2.3 Cochlear Implants
- 9.2.4 Neurostimulators
- 9.2.5 Drug Pumps
-
9.3 LATAM Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 9.3.1 Healthcare
- 9.3.2 Hospitals
- 9.3.3 Neurosurgery
- 9.3.4 Cardiology
- 9.3.5 Biotech
- 9.4 LATAM Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 9.5 LATAM Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 9.6 LATAM Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 10 : West Europe Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 10.1 West Europe Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 10.2.1 Pacemakers
- 10.2.2 Defibrillators
- 10.2.3 Cochlear Implants
- 10.2.4 Neurostimulators
- 10.2.5 Drug Pumps
-
10.3 West Europe Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 10.3.1 Healthcare
- 10.3.2 Hospitals
- 10.3.3 Neurosurgery
- 10.3.4 Cardiology
- 10.3.5 Biotech
- 10.4 West Europe Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 10.5 West Europe Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 10.6 West Europe Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 11 : Central & Eastern Europe Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 11.2.1 Pacemakers
- 11.2.2 Defibrillators
- 11.2.3 Cochlear Implants
- 11.2.4 Neurostimulators
- 11.2.5 Drug Pumps
-
11.3 Central & Eastern Europe Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 11.3.1 Healthcare
- 11.3.2 Hospitals
- 11.3.3 Neurosurgery
- 11.3.4 Cardiology
- 11.3.5 Biotech
- 11.4 Central & Eastern Europe Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 11.5 Central & Eastern Europe Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 11.6 Central & Eastern Europe Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 12 : Northern Europe Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 12.2.1 Pacemakers
- 12.2.2 Defibrillators
- 12.2.3 Cochlear Implants
- 12.2.4 Neurostimulators
- 12.2.5 Drug Pumps
-
12.3 Northern Europe Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 12.3.1 Healthcare
- 12.3.2 Hospitals
- 12.3.3 Neurosurgery
- 12.3.4 Cardiology
- 12.3.5 Biotech
- 12.4 Northern Europe Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 12.5 Northern Europe Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 12.6 Northern Europe Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 13 : Southern Europe Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 13.2.1 Pacemakers
- 13.2.2 Defibrillators
- 13.2.3 Cochlear Implants
- 13.2.4 Neurostimulators
- 13.2.5 Drug Pumps
-
13.3 Southern Europe Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 13.3.1 Healthcare
- 13.3.2 Hospitals
- 13.3.3 Neurosurgery
- 13.3.4 Cardiology
- 13.3.5 Biotech
- 13.4 Southern Europe Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 13.5 Southern Europe Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 13.6 Southern Europe Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 14 : East Asia Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 14.1 East Asia Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 14.2.1 Pacemakers
- 14.2.2 Defibrillators
- 14.2.3 Cochlear Implants
- 14.2.4 Neurostimulators
- 14.2.5 Drug Pumps
-
14.3 East Asia Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 14.3.1 Healthcare
- 14.3.2 Hospitals
- 14.3.3 Neurosurgery
- 14.3.4 Cardiology
- 14.3.5 Biotech
- 14.4 East Asia Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 14.5 East Asia Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 14.6 East Asia Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 15 : Southeast Asia Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 15.2.1 Pacemakers
- 15.2.2 Defibrillators
- 15.2.3 Cochlear Implants
- 15.2.4 Neurostimulators
- 15.2.5 Drug Pumps
-
15.3 Southeast Asia Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 15.3.1 Healthcare
- 15.3.2 Hospitals
- 15.3.3 Neurosurgery
- 15.3.4 Cardiology
- 15.3.5 Biotech
- 15.4 Southeast Asia Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 15.5 Southeast Asia Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 15.6 Southeast Asia Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 16 : South Asia Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 16.1 South Asia Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 16.2.1 Pacemakers
- 16.2.2 Defibrillators
- 16.2.3 Cochlear Implants
- 16.2.4 Neurostimulators
- 16.2.5 Drug Pumps
-
16.3 South Asia Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 16.3.1 Healthcare
- 16.3.2 Hospitals
- 16.3.3 Neurosurgery
- 16.3.4 Cardiology
- 16.3.5 Biotech
- 16.4 South Asia Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 16.5 South Asia Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 16.6 South Asia Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 17 : Central Asia Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 17.1 Central Asia Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 17.2.1 Pacemakers
- 17.2.2 Defibrillators
- 17.2.3 Cochlear Implants
- 17.2.4 Neurostimulators
- 17.2.5 Drug Pumps
-
17.3 Central Asia Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 17.3.1 Healthcare
- 17.3.2 Hospitals
- 17.3.3 Neurosurgery
- 17.3.4 Cardiology
- 17.3.5 Biotech
- 17.4 Central Asia Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 17.5 Central Asia Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 17.6 Central Asia Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 18 : Oceania Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 18.1 Oceania Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 18.2.1 Pacemakers
- 18.2.2 Defibrillators
- 18.2.3 Cochlear Implants
- 18.2.4 Neurostimulators
- 18.2.5 Drug Pumps
-
18.3 Oceania Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 18.3.1 Healthcare
- 18.3.2 Hospitals
- 18.3.3 Neurosurgery
- 18.3.4 Cardiology
- 18.3.5 Biotech
- 18.4 Oceania Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 18.5 Oceania Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 18.6 Oceania Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 19 : MEA Active Implantable Medical Devices Market Breakdown by Country, Type & Application
- 19.1 MEA Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 19.2.1 Pacemakers
- 19.2.2 Defibrillators
- 19.2.3 Cochlear Implants
- 19.2.4 Neurostimulators
- 19.2.5 Drug Pumps
-
19.3 MEA Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 19.3.1 Healthcare
- 19.3.2 Hospitals
- 19.3.3 Neurosurgery
- 19.3.4 Cardiology
- 19.3.5 Biotech
- 19.4 MEA Active Implantable Medical Devices Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 19.5 MEA Active Implantable Medical Devices Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 19.6 MEA Active Implantable Medical Devices Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Active Implantable Medical Devices market is estimated to derive a market size of 18Billion by 2031.
The Active Implantable Medical Devices Market is estimated to grow at a CAGR of 20%, currently pegged at 7Billion.
The changing dynamics and trends such as Minimally Invasive, Personalization, Biocompatibility are seen as major Game Changer in Global Active Implantable Medical Devices Market.
The leaders in the Global Active Implantable Medical Devices Market such as Medtronic (Ireland), Abbott Laboratories (United States), Boston Scientific Corporation (United States), BIOTRONIK (Germany), LivaNova PLC (United Kingdom), Cochlear Limited (Australia), MED-EL (Austria), Sonova (Switzerland), Demant (Denmark), Nurotron Biotechnology (United States) are targeting innovative and differentiated growth drivers some of them are The Increasing Number Of Patients With Cardiovascular Diseases And Neurological Disorders,,
Growth In Aging Population,,
Demand For Implantable Cardioverter Defibrillators,,
The Increasing Focus On R&D Is A Key Trend
As Industry players prepare to scale up, Active Implantable Medical Devices Market sees major concern such as Regulation, Sourcing.
Some of the opportunities that Analyst at HTF MI have identified in Active Implantable Medical Devices Market are:
- Healthcare Reforms For Infrastructural Development
- Technological Advancements In Developing Novel Active Implantable Devices
Medtronic (Ireland), Abbott Laboratories (United States), Boston Scientific Corporation (United States), BIOTRONIK (Germany), LivaNova PLC (United Kingdom), Cochlear Limited (Australia), MED-EL (Austria), Sonova (Switzerland), Demant (Denmark), Nurotron Biotechnology (United States) are the major operating companies profiled in Active Implantable Medical Devices market study.
The Global Active Implantable Medical Devices Market Study is Broken down by applications such as Healthcare, Hospitals, Neurosurgery, Cardiology, Biotech.
The Global Active Implantable Medical Devices Market Study is segmented by Pacemakers, Defibrillators, Cochlear Implants, Neurostimulators, Drug Pumps.
The Global Active Implantable Medical Devices Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2019 - Base year: 2023. Forecast period**: 2025 to 2031 [** unless otherwise stated]
An active implantable medical device is a device, which is hereby intended to be either wholly or partially put into the human body surgically or medically or through the process of a medical procedure into a natural opening and that it should remain inside the body even after the procedure. It is a medical device that is intended to be wholly or partially introduced into the human body for diagnostic or therapeutic purposes and is intended to remain in place. These benefit remarkably from the increasing spread of several chronic diseases such as cardiovascular and neurological diseases. The constant product launches and the simplified approval process also support the growth of this market considerably.
